Homocysteine is an independent cardiovascular disease (CVD) risk factor modi fiable by nutrition and possibly exercise. While individuals participating in regular physical activity can modify CVD risk factors, such as total blood cholesterol levels, the impact physical activity has on blood homocysteine concentrations is unclear. This review examines the influence of nutrition and exercise on blood homocysteine levels, the mechanisms of how physical activity may alter homocys teine levels, the role of homocysteine in CVD, evidence to support homocysteine as an independent risk factor for CVD, mechanisms of how homocysteine increases CVD risk, and cutoff values for homocysteinemia. Research examining the impact of physical activity on blood homocysteine levels is equivocal, which is partially due to a lack of control for confounding variables that impact homocysteine. Duration, intensity, and mode of exercise appear to impact blood homocysteine levels differently, and may be dependent on individual fitness levels.
Based on the above studies, researchers have identified elevated blood homocysteine as an independent risk factor for CVD further stimulating research examining various factors that impact blood homocysteine levels. We now know a number of factors influence homocysteine levels, such as age, gender, genetics, medications, and lifestyle factors, such as alcohol intake, smoking, nutrition, and physical activity (83) .
This review focuses on the impact of two lifestyle factors, nutrition and physical activity, on blood homocysteine concentrations. First, homocysteine metabolism is described. Second, the role that nutrition, especially the Bvitamins, has on homo cysteine metabolism is reviewed. Third, the mechanisms of how physical activity may alter homocysteine levels are presented. Fourth, the role of homocysteine in CVD is discussed including evidence to support homocysteine as an independent risk factor, mechanisms related to homocysteine and CVD, and a definition of homocysteinemia. Finally, a review of the epidemiological, crosssectional, and experimental research examining the impact of physical activity on blood homo cysteine levels are presented.
Homocysteine Metabolism
Homocysteine is a normal metabolite of the essential amino acid methionine ( Figure 1 ). Structurally, it closely resembles methionine and cysteine; all three amino acids contain sulfur. They are metabolically linked to each other as shown in Figure 1 . Methionine is first converted to sadenosylmethionine and further Adapted with permission from reference (45) ATP, adenosine triphosphate; Pi, inorganic phosphate; Ppi, inorganic pyrophosphate; TH4, tetra hydrofolate processed to sadenosylhomocysteine before conversion to homocysteine. Once converted to homocysteine, it has two fates: 1) remethylation from homocysteine back into methionine or 2) transsulfuration from homocysteine into cystathionine with further metabolism to cysteine. Four key enzymes are involved in this com plex metabolic pathway, methyltetrahydrofolate reductase, methionine synthase, cystathionineβsynthase, and cystathionineγlyase, which rely on vitamins as cofactors to function properly ( Figure 1 ). For more biochemical details of homo cysteine metabolism, refer to references 12 and 72.
Role of Nutrition
Homocysteine metabolism is driven by several Bcomplex cofactors. Folate, vitamin B6, and vitamin B12 are used in the remethylation pathway, and vitamin B6 is used in the transsulfuration pathway ( Figure 1 ). Deficiencies of folate, vitamin B6, or vitamin B12 can lead to impaired homocysteine metabolism. In addition, the amount of dietary methionine consumed influences homocysteine metabolism. Thus, these factors will either increase or decrease blood homocysteine, depending on dietary levels.
Dietary Methionine. When dietary methionine intake is high, the transsulfura tion pathway is promoted over remethylation resulting in homocysteine catabo lism to cysteine. Conversely, when dietary methionine is low, the remethylation pathway is favored over transsulfuration to elicit de novo methionine synthesis. A methioninerich meal (e.g., meal high in animal protein) has been shown to cause an acute increase in homocysteine, which may last up to 24 h in healthy adults (35) . Further, methionineloading tests are often used to study the efficiency of homocysteine metabolism (2) . Dietary methionine is found in proteinrich foods such as red meat, poultry, and cheese. Individuals consuming diets high in animal protein have reported increased methionine metabolism and higher homocysteine levels than vegetarians (50) . However, some vegetarians and strict vegans may have low dietary intakes of methionine and vitamin B12 resulting in high blood homocysteine levels (44) . Thus, individuals consuming lower meat and animal protein diets with adequate intakes of Bvitamins may be able to keep homocysteine concentrations low (24) .
B-Vitamin Status. The Bvitamins play critical roles in both the remethylation and transulfuration pathways of methionine metabolism (Figure 1 ). The enzyme, methionine synthase, which is involved with the remethylation reaction converting homocysteine to methionine, requires both folate and vitamin B12 as coenzymes. The transsulfuration pathway converts homocysteine to cysteine in a series of vita min B6 dependent reactions, which requires vitamin B6 as a coenzyme for the enzymes cystathionineβsynthase and cystathionineγlyase. Therefore, adequate folate, vitamin B12, and vitamin B6 are critical for the enzymes in these pathways to function optimally in order to maintain homocysteine homeostasis. Both the amount of dietary intake and the blood vitamin levels of an individual contribute to their nutritional status. Reduced dietary intake and/or blood levels of these vitamins contribute to an accumulation of blood homocysteine.
Folate insufficiency is the predominant nutritional cause of elevated blood homocysteine in most healthy populations. Research indicates that individuals with diets high in folate or folic acid supplements are able to reduce blood homocysteine concentrations (9, 10, 87) , especially in individuals with low folate status and high homocysteine levels (20) . Research also shows that folic acid supplements given to individuals with normal folate status can further lower homocysteine concentra tions (46) . Vitamin B12 and, to a lesser extent, vitamin B6 supplements are also effective at lowering homocysteine, either individually or in combination with folic acid supplements in individuals who have high blood homocysteine levels (77, 80) . Therefore, a major contributing factor to high levels of blood homocysteine is a diet low in these three vitamins.
Based on recent data, not all Americans, especially women, consume enough folate, vitamin B6, or vitamin B12, even with the 1998 mandate of folic acid fortification to cereal grain products (25) (41) . They found 10% of the athletes deficient in vitamin B12 and 15% deficient in folate based on serum levels. Thus, being physically active does not necessarily equate to a healthier nutritional status. Active and inactive individuals may have poor nutritional status, which may influence homocysteine levels independent of the amount, intensity, or type of exercise.
Role of Physical Activity
In addition to adequate nutrition, there is evidence that physical activity may also alter homocysteine production by increasing protein and/or methyl group turnover. These hypothesized mechanisms are discussed below.
Protein Turnover. During exercise, protein turnover could alter homocysteine con centrations by either increasing methionine catabolism, thus lowering homocysteine, or by decreasing Bvitamin availability, which would increase homocysteine.
It is well documented that prolonged highintensity exercise (33, 84) increases protein metabolism and alters blood concentrations of certain amino acids (30) . For example, Weiss et al. reported a 33% reduction in blood methionine levels in college students after a 2.5 h moderate intensity run (88) . Reduced methionine availability would promote de novo methionine synthesis and, thus, reduce accumu lation of homocysteine. In this way, the protein turnover mechanism would lower homocysteine concentrations during high intensity prolonged exercise, as long as folate, vitamins B6 and B12 were adequate.
Conversely, prolonged exercise, where glycogen reserves are reduced, places an increased demand on vitamin B6 dependent reactions. Pyridoxal 5' phosphate (PLP), the most biologically active form of vitamin B6, is a coenzyme for trans aminases, decarboxylases, and other enzymes used in the metabolic transforma tions of amino acids and nitrogen containing compounds. PLP is also required for glycogen phosphorylase, the key enzyme in the breakdown of muscle glycogen.
In addition, during exercise, gluconeogenesis involves the breakdown of amino acids, with the carbon skeleton used for energy. If exercise increases the demand for vitamin B6 or increases its losses, less vitamin B6 would be available for homocysteine catabolism. In this way, increased protein turnover during prolonged exercise would increase homocysteine concentrations.
Methyl Group Turnover. Highintensity exercise elicits an increase in methyl group turnover, which could increase homocysteine production. As shown in Figure 1 , methionine is first converted to sadenosylmethionine, which is the most important methyl group donator in humans. A sufficient supply of methyl groups is important in several biochemical pathways, of which many are exercise related, such as the synthesis of DNA, RNA, carnitine, choline, acetylecholine, phosphatidyl choline, epinephrine, adrenalin, methylhistadine, and creatine (60, 72, 82) . Creatine synthesis in the liver accounts for nearly 75% of daily homocysteine formation (72) , where sadenosylmethionine donates its methyl group to guanidinoacetate to form creatine and sadenosylhomocysteine ( Figure 1 ). Highintensity exercise relies on creatine phosphate for muscle contractions, where creatine reacts with the adenosyltriphosphate (ATP) produced by glycolysis and oxidative phosphorylation, to form ADP and creatine phosphate. During exercise, when muscle ATP is being consumed, the highenergy phosphate group of creatine phosphate is transferred to ADP to restore ATP. Creatine is then recycled or converted to creatinine, which is excreted in the urine. Thus, highintensity longduration physical activity, which increases the demand for creatine, increases homocysteine production compared with lessintense shortduration physical activity. Further, when creatine is taken orally, the endogenous production of creatine decreases, which also decreases the endogenous production of homocysteine. A recent study examined the effects of a 4 wk oral creatine supplementation (amount of creatine taken each day was equal to twice their creatinine excretion; 2.1 to 5.1 g/d) in healthy adults ranging in age from 21 to 58 y (48). The experimental group had a significant reduction in homocysteine production (n = 8; -0.9 µmol/L) compared to the control group (n = 8; +0.2 µmol/L) (P < 0.05), supporting that when endogenous creatine is made, blood homocysteine levels may rise. Thus, an increase in methyl group turnover increases homocysteine production.
Homocysteine and CVD
For many individuals, CVD cannot be fully explained by the traditional risk fac tors such as hypertension and high blood cholesterol levels. For example, 35% of coronary heart disease cases occur in individuals with total cholesterol levels < 200 mg/dL (54) . Other risk factors, such as blood homocysteine concentrations, appear to have strong relationships with CVD. This section reviews evidence sup porting homocysteine as an independent risk factor for CVD, discusses the proposed mechanisms whereby homocysteine contributes to CVD, and examines the levels of blood homocysteine concentrations associated with increased CVD risk.
Homocysteine as a CVD Risk Factor
Extensive research supporting high blood homocysteine levels as an independent CVD risk factor is summarized in current metaanalyses, review articles, and clinical trials. The first metaanalysis was completed by Boushey et al., who included 27 studies involving more than 4000 patients with occlusive vascular disease (cardiovascular, peripheral, and cerebrovascular) and an equal number of controls (8) . Results showed that homocysteine was an independent risk factor for atherosclerotic disease in the coronary, cerebral, and peripheral vessels, and that a 5 µmol/L increment increase in total plasma homocysteine levels was associated with a 60% increased risk for coronary heart disease in men and an 80% increased risk for women (8) . This study was followed by two more metaanalyses that also supported the relationship between high homocysteine levels and CVD (15, 86) . The Homocysteine Studies Collaboration (15), a compilation of prospective and retrospective studies using a total of 5073 heart disease events and 1113 stroke events, found that a 25% lower than usual blood homocysteine concentration (~ 3 µmol/L lower) was associated with an 11% lower heart disease risk (15) . In addition, Wald et al. completed a metaanalysis that used 72 studies in which the prevalence of a mutation in the methyltetrahydrofolate reductase gene, which increases homocysteine, was determined in cases and controls (n = 16,849) as well as 20 prospective studies with 3820 participants (86) . They concluded from these studies that by lowering blood homocysteine concentrations by 3 µmol/L from current levels, the risk of ischaemic heart disease was reduced by 16% and deep vein thrombosis reduced by 25% (86) . Finally, Refsum and Ueland completed an extensive review examining the relationship between CVD mortality and blood homocysteine concentrations (66) . They reviewed 80 studies, including more than 10,000 patients of crosssectional, case control, nested case control, and cohort populations and found that blood homocysteine concentration was a prevalent and strong risk factor for atherosclerotic vascular disease in the coronary, cerebral, and peripheral vessels, and for arterial and venous thromboembolism. They concluded high blood homocysteine levels confers a graded increased risk with no threshold, is independent of and may enhance the effect of the conventional risk factors, and seems to be a particularly strong predictor of cardiovascular mortality.
Clinical trials have also examined the association between myocardial infarct (MI) and increased homocysteine levels. Stampfer et al. completed a clinical trial using 14,916 male physicians, age 40 to 84 y, with no prior MI (75). They measured plasma homocysteine concentrations at baseline and after 5 y. Blood samples from 271 men who subsequently developed MI were analyzed for homocysteine levels together with paired controls, matched by age and smoking. They concluded that moderately high levels of plasma homocysteine were associated with subsequent risk of MI independent of other coronary risk factors (75) . This finding was sup ported by a more recent clinical trial by Zylberstein et al., where 1368 women were followed for 24 y (93). These researchers found that blood homocysteine levels in excess of 14.2 µmol/L in middleage women was an independent risk factor for future MI, particularly fatal events (93) . Collectively, these studies strongly sug gest that elevated blood homocysteine levels increase risk of CVD, independent of other CVD risk factors.
Mechanism: How Does Elevated Blood Homocysteine Increase CVD Risk?
Homocysteine appears to have a wide variety of adverse effects on vascular physiology that contributes to increased cardiovascular risk. The most commonly suggested mechanisms explaining the link between CVD and homocysteine are endothelial dysfunction and platelet aggregation/thrombosis. These mechanisms are briefly reviewed here.
Endothelial Dysfunction. Homocysteine may promote atherosclerosis by induc ing endothelial dysfunction, which is characterized as a loss in vasodilation control in blood vessel cells. In cell culture studies, homocysteine inhibits endothelium dependent anticoagulant reactions (39, 52, 68) , induces the expression of proco agulants (31, 68) , decreases interactions between endothelial cells and plasminogen activators (36, 37) , and impairs the bioavailability of endotheliumderived nitric oxide (74) . These findings are supported by animal studies in minipigs and rats, which have showed specific structural abnormalities in the large arteries with ele vated blood homocysteine levels (13, 59, 69) . Studies in cynomolgus monkeys also showed that high blood homocysteine levels impaired responses to endothelium dependent vasodilators, such as nitric oxide (53) . Nitric oxide allows the smooth muscle of blood vessels to relax or dilate, which creates greater blood flow when the demand for oxygen is high, such as during exercise. Therefore, an impaired response to nitric oxide would inhibit blood vessel dilation.
Human studies also support a relationship between high blood homocysteine levels and endothelial dysfunction via impaired nitric oxide release (70, 78) . Degradation of nitric oxide via abnormal interaction with the free thiol moiety of homocysteine may decrease the bioavailability of nitric oxide. Thiols are proposed to react with nitric oxide to form snitrosothiols, which have both potent vaso dilation and antiplatelet effects. Woo et al. found endothelialdependent dilation was significantly lower in subjects with high homocysteine levels when compared to those with low homocysteine levels (P < 0.001) (91) . In addition, Dinckal et al. demonstrated the relationship between homocysteine and endothelialdependent dilation by placing subjects on a 4wk homocysteine lowering diet, which included Bvitamin supplements (26) . They found significant reductions in blood homocys teine concentrations and significant improvements in endothelialdependent dilation in comparison to the placebo group (26) .
Platelet Aggregation and Thrombosis. Platelet aggregation is a clustering of platelets and/or blood cell fragments, which can lead to the formation of blood clots. Thrombosis is the formation or presence of one or more blood clots that may partially or completely obstruct the flow of blood through the circulatory system. The most convincing research that supports homocysteine's role in platelet aggregation and thrombosis is via oxidative stress mechanisms. The oxidative damage caused by hydrogen peroxide during the oxidation of homocysteine may increase platelet activity. Specifically, the SH group of homocysteine is oxidized to a disulfide bond (SS) in a reaction that is coupled to the formation of reactive oxygen species, such as hydrogen peroxide. In turn, these reactive species cause endothelial dysfunction, decrease nitric oxide production, and therefore accelerate atherosclerosis (34) . However, direct generation of reactive oxygen species by homocysteine is unlikely to have physiological relevance, but it is probable that oxidative stress is a second ary effect. See the review by Edirisinghe for this mechanism (28) . Animal studies done in mice support a relationship between high blood levels of homocysteine and oxidative stress by activating signal transduction pathways leading to inflammation and apoptosis (90) . However, in humans it has been much more difficult to find this relationship. Selhub argues that human studies provided inconclusive results when looking for thrombogenic abnormalities in patients with high blood levels of homocysteine (72) . He suggested the abnormalities observed in human studies are due to inconsistencies in genetic background, dietary habits, and pathology differences among sample populations.
In summary, cell culture, animal and human research all support a relationship between high homocysteine levels and endothelial dysfunction. It appears high blood homocysteine levels are partially responsible for endothelial dysfunction and high concentrations may attenuate platelet aggregation and thrombosis. Currently, not one unifying hypothesis exists that explains the mechanistic effects of high levels of circulating homocysteine on CVD.
What is Elevated Blood Homocysteine?
What level of blood homocysteine is associated with a higher risk of CVD? Some researchers argue that the lowest level of blood homocysteine possible is ideal (85); however, not everyone agrees on a single value or range of homocysteine that represents the lowest risk of CVD. The term hyperhomocysteinemia is used to describe an individual with elevated blood homocysteine concentrations, yet there is no standard upper level cutoff value. Hyperhomocysteinemia values vary among published reports, with studies typically using the 95th percentile values as a high cutoff point in their reported control samples.
Stamper et al. was the first to publish reference ranges based on the 95th per centile cutoff point. They reported a 95th percentile value of 15.8 µmol/L for US white men (75) . In South Africa, Ubbink et al. used men's responses to vitamin supplementation to develop a mathematical prediction model to calculate the plasma homocysteine concentration that could be expected for individuals treated with a vitamin supplement (81) . They predicted that plasma homocysteine concentrations would approach a normal frequency distribution with a 95% reference range of 4.9 to 11.7µmol/L for adult white men, provided that the vitamin status of the study population is improved (81) . Data extracted from the Third National Health and Nutrition Examination Survey (NHANES 19911994) helped to identify reference ranges for serum total homocysteine concentration in US men and women (73) . For individuals age 20 to 39 y, the 95th percentile for blood homocysteine concentrations were ≥ 11.4 µmol/L for men and ≥ 10.4 µmol/L for women. Finally, the Nutrition Committee of the American Heart Association suggested a blood homocysteine level < 10 µmol/L is a reasonable therapeutic goal for individuals at increased risk. They determined it was better to have a goal level of blood homocysteine rather than using the definition of "normal" based on population statistical values of the mean ± 2 standard deviations (56) .
Regardless of the upper cutoff values for blood homocysteine, risk for CVD rises with increasing homocysteine concentrations. In general, blood homocysteine concentrations increase with age and are higher in men than in women. A review by Boushey et al. found a 60 to 80% greater risk for CVD for each 5 µmol/L increment of plasma homocysteine concentration > 10 µmol/L and suggested this increase in risk is similar to a 0.5 mmol/L (20 mg/dL) increase in total blood cholesterol (8) . Furthermore, as mentioned earlier, some reports suggest that reducing blood homocysteine concentrations by 3 µmol/L reduces chronic disease risk by as much as 25% (15, 86) . However, recent clinical trials using blood homocysteine lowering therapies (Bvitamin supplementation vs. placebo) in individuals with previous heart attacks or strokes have not been successful at lowering risk of recurrent events with supplementation (7, 79) . These data suggest maintaining the lowest possible blood homocysteine concentration throughout the lifespan may help keep chronic disease risk low.
Physical Activity and Homocysteine
Increased physical activity in previously sedentary individuals modifies known risk factors for CVD, including improvements in circulating levels of total serum cholesterol, blood pressure, and cardiorespiratory fitness (VO 2max ) (5) . Although the effects of exercise on these traditional risk factors are well documented, few studies have addressed whether physical activity can modify blood homocysteine. This section reviews the current literature that examines the relationship between physical activity and blood homocysteine concentrations in epidemiology, cross sectional, and intervention/experimental studies.
Epidemiology Research
Currently, there has only been one large populationbased study that examines the relationship between lifestyle activeness and blood homocysteine concentrations. Nygard et al. examined the relationship between physical activity and homocysteine in the Hordland Homocysteine Study (Norway) (63). They found selfreported leisure time physical activity was negatively associated with blood homocysteine concentrations (P < 0.001) in both men and women. Participants reported their leisure time physical activity for the year prior to the study in one of four catego ries (sedentary/none, moderate activity, active exercise, heavy training). Those individuals with the highest leisure time physical activity had the lowest levels of blood homocysteine. The difference in blood homocysteine levels between the sedentary and highly active groups was 0.76 µmol/L in men and 0.94 µmol/L in women; however, very few individuals were in the highly active groups (147 men and 51 women; total N = 12,263). Unfortunately, Bvitamin status was not reported for these individuals. However, when the researchers statistically adjusted for higher fruit and vegetable consumption and supplement use, they found significantly lower blood homocysteine levels (P < 0.01) (63) . This study stimulated interest in the relationship between physical activity, diet, and homocysteine levels and prompted many of the research studies discussed in the next section.
Cross-Sectional Research
To date, nine crosssectional studies have examined the association between physical activity and homocysteine by using selfreported questionnaires, personal standard ized interviews, and/or fitness levels determined by measured VO 2max to describe individual physical activity levels ( Table 1) . Two of these studies (55, 71) found no significant relationship between the level of blood homocysteine concentrations and physical activity levels. One study by Saw et al. found higher amounts of physical activity was associated with lower homocysteine levels in Chinese men and women before statistically controlling for folate status, but after multivariate adjustment there was no difference between exercisers and nonexercisers (71) . Unfortu nately, individuals in this study were considered exercisers if they selfreported 4 All dietary intake data was reported using Food Frequency Questionnaires, which measured average intake per week over the previous year for consumption of particular foods or food groups. Approximate frequency of consumption was then quantified in terms of the number of times a month a food was consumed. ↓ Lower homocysteine concentrations in the group most physically active ↑ Higher homocysteine concentrations in the group most physically active * Compared with resistance exercise or a sedentary lifestyle participating in at least 0.5 h of physical activity a week, such as brisk walking, bowling, tai chi, chi kung, jogging, tennis, or swimming laps. This duration and/or frequency of activity may be too low to determine whether blood homocysteine levels are different between exercisers and nonexercisers. Two strengths of this study were that Bvitamin status was evaluated using both dietary intake and blood measurements and hours of television watching was reported to further understand the activeness of their participants (71) .
Five crosssectional studies showed lower blood homocysteine levels in indi viduals reporting higher levels of physical activity (14, 18, 40, 49, 51 ), but none of these studies statistically adjusted for Bvitamin status based on blood measures and dietary intake.
Finally, two crosssectional studies showed a positive relationship between homocysteine and physical activity levels. Rinder et al. reported higher homocys teine levels in exercisers when compared to nonexercisers. They compared ten competitive master male athletes (68.5 ± 1.4 y) to inactive controls (64.5 ± 2.3 y) and found blood homocysteine concentrations in the athletes to be significantly higher (10.7 ± 1.3 µmol/L) when compared to controls (9.2 ± 1.4 µmol/L) (P = 0.02) (67) . De Bree et al. also found a similar relationship between physical activ ity and homocysteine, but only in women (19) . They examined a random sample of Dutch men and women (20 to 65 y) and found no association between physical activity and homocysteine levels in men. However, for women, they found a posi tive relationship between physical activity and plasma homocysteine levels while adjusting for age, dietary folate intake, vitamin supplement use, and other lifestyle factors. Thus, as hours of physical activity increased, so did blood homocysteine levels in females (19) .
In summary, these nine crosssectional studies reported equivocal results with no clear consensus as to whether physical activeness negatively or positively impacts blood homocysteine levels. There are a number of confounders that may have contributed to the mixed observations in these studies: 1) nutritional status parameters were not assessed or accounted for; 2) age ranged widely within each study; 3) individuals selfreported their physical activity levels, which are often overestimated; and 4) level of physical activity and/or fitness level was defined differently among the studies making comparisons between studies difficult.
Exercise Interventions
Many experimental studies have examined the impact of physical activity on homocysteine levels (Tables 2 through 4) with varying degrees of exercise intensity and length of exercise interventions. Therefore, these studies are divided into three categories: 1) acute exercise, defined as one episode of physical activity lasting between 10 to 210 min; 2) chronic exercise, defined as a physical activity program lasting 10 d or more in previously active individuals; and 3) in previously sedentary individuals.
Acute Exercise. Seven studies have examined the effect of acute exercise on blood homocysteine levels in active individuals. As summarized in Table 2 , three studies found no effect (21, 22, 92) , three studies found exercise to increase homo cysteine levels (42, 47, 88) , while one study found acute exercise to decrease blood homocysteine levels (32) .
The three studies reporting an increase in homocysteine levels with acute exercise had 60 min or longer duration of physical activity, but none of these studies statistically adjusted for Bvitamin status based on both blood measures and dietary intake (42, 47, 88) . The three studies finding no effects of acute exer cise on blood homocysteine concentrations were all ≤ 60 min in duration and used moderateintensity stationary cycling, possibly not rigorous enough to elicit changes (21, 22, 92) .
Two factors that may influence the effect of physical activity on blood homocysteine levels are exercise mode and intensity. For example, Herrmann et al. compared blood homocysteine levels of marathon runners, 100 km runners, Blood homocysteine concentrations ↓ lower homocysteine concentrations at the end of exercise compared to baseline ↑ higher homocysteine concentrations at the end of exercise compared to baseline ≠ no change in homocysteine concentrations * blood vitamins only measured/statistically controlled for in individuals with >12 µmol [Hcy] (n = 23) and mountain bikers before and after their respective races (42) . Only marathon runners had significantly higher homocysteine levels after racing when compared to baseline levels (P < 0.05). When groups were compared, homocysteine values were significantly different among the groups at 15 min postrace (median values: marathon runners (16.1 µmol/L), 100 km runners (9.5 µmol/L), and mountain bikers (8.8 µmol/L); P < 0.05). The authors suggest the accumulation of homocysteine is higher in marathon runners because it is a sustained highintensity, longduration event, whereas, 100 km running is lower in intensity and may have brief occasions of rest similar to mountain biking downhill (42) . To date, no intervention studies have examined the impact of acute exercise on blood homocysteine concentrations in sedentary individuals.
Chronic Exercise. Ten studies have examined the effect of chronic exercise, programs lasting from 2 to 25 wk, on blood homocysteine levels in active (Table 3) and sedentary (Table 4) individuals.
Active Individuals. As shown in Table 3 , a total of five studies report no consistent blood homocysteine response to exercise training programs in previously active Blood homocysteine concentrations ≠ no change in homocysteine concentrations ↓ lower homocysteine concentrations at the end of program compared to baseline ↑ higher homocysteine concentrations at the end of program compared to baseline * only subgroup had significant difference: triathletes training 14.9 h/wk had a decrease from 12.7 to 11.7µm/L as compared with levels of 12.5 to 12.86µm/L in the triathletes training 9.1 h/wk (P < 0.05).
individuals (3, 21, 43, 47, 76) . One study showed a 10% increase in blood homo cysteine levels in 14 active young (22 y) men training (70 to 85% max heart rate) for 4 wk with cycle ergometers (P < 0.05) (3). Conversely, Konig et al. found 30 d of triathlon training lowered homocysteine levels in welltrained male triathletes (n = 39). However, the significantly lower blood homocysteine concentrations were only found in the triathletes (n = 9) reporting the highest amount of training volume (> 14.9 h/wk) when compared to the group with the lowest training volume (< 9.1 h/wk) (P < 0.05) (47).
Herrmann et al. examined the impact of swimming on blood homocysteine concentrations and found a 10% increase in blood homocysteine levels induced by both highintensity training (20 km/wk) and volumeoriented training (30 km/wk), yet these increases were not statistically significant, P = 0.070 and P = 0.054, respectively (43) . De Cree et al. also reported no significant change in blood homo cysteine levels with 10 d of high intensity cycleergometer training in females (21). Blood homocysteine concentrations ↓ lower homocysteine concentrations at the end of program compared to baseline ≠ no change in homocysteine concentrations ↑ higher homocysteine concentrations at the end of program compared to baseline ML, moderate intensity, low frequency; MH, moderate intensity, high frequency; HH, high intensity, high frequency; HL, high intensity, low frequency Finally, only one study has examined blood homocysteine response to resistance training (76) . There were no differences in blood homocysteine levels found in a small group of women (n = 5) participating in a weighttraining program for 8 wk (76) . Details about the weight lifting program were not reported. The intensity or frequency of the training program might have impacted the results.
In summary, these studies do not show a consistent effect of chronic exercise on blood homocysteine levels in active individuals. However, only three of the five studies reported blood Bvitamin levels and none reported Bvitamin intake, thus, adding to the variable results. In addition, it may be that significant effects were not found in three of these studies because individuals were described as active prior to the beginning of the study intervention and therefore, did not perform more exercise than their normal routines, which did not elicit a change in blood homocysteine over the course of the intervention.
Sedentary Individuals. As shown in Table 4 , when sedentary individuals par ticipated in exercise training, blood homocysteine levels varied in response. For example, Cooper et al. and de Jong et al. found no significant changes in blood homocysteine levels in men who participated in a 6wk walking program or in elderly adults who completed a variety of lowimpact exercises for 17 wk, respec tively (17, 23) . However, in both of these studies the exercise intensity was very low, and may have not been high enough to elicit a change in blood homocysteine concentrations.
As demonstrated by Duncan et al., intensity of the exercise may be a factor that modifies blood homocysteine (27) . In this study, sedentary individuals were placed into one of four different exercise programs, high intensityhigh frequency, high intensitylow frequency, moderate intensityhigh frequency, or moderate intensitylow frequency. Homocysteine levels significantly increased in the high intensityhigh frequency and the high intensitylow frequency groups compared to baseline values after 6 months of training (P < 0.003), but not in the moderate intensity groups (27) . Conversely, others have found that low to moderate intensity exercise decreases homocysteine in individuals with health issues. Ali et al. reported that a 12wk moderateintensity aerobictype exercise program decreased blood homocysteine levels in male phase II cardiac rehabilitation patients (1). Randeva et al. also reported a decrease in blood homocysteine levels in overweight women with polycystic ovary syndrome participating in a walking exercise program for 25 wk (65) .
In summary, all of the exercise intervention programs used diverse exercise programs varying in program length (2 to 25 wk), exercise intensity and mode (brisk walking, cycling, swimming, running, weight training, etc.), and frequency (3 to 7 d/wk), which may be the reason for the varied results. In addition, health status varies among individuals, from those considered healthy to those with compromised health, which influences various metabolic pathways.
Conclusions
As illustrated in Figure 2 , there is an interrelationship between nutrition, exercise, and homocysteine. Proper intake of vitamins B6, B12, and folate can help to maintain low homocysteine levels and support the increased demands on metabo lism during highintensity and/or prolonged exercise. For example, exercise may increase the need for vitamin B6 since it is involved in many biochemical reactions necessary to fuel working muscles and repair damaged tissue (57, 58) .
Based on research conducted over the last 10 y, no consistent relationship exists between physical activity and blood homocysteine concentrations. The impact of physical activity on blood homocysteine concentrations appears to vary based on fit ness levels, nutritional status, genetic, or other factors that were either not measured or accounted for in the studies reviewed. The primary variables, excluding dietary factors, which help explain the inconsistencies in blood homocysteine levels, may be the mode, intensity, and duration of exercise. If these variables impact blood homocysteine concentrations, it may be relative to individual fitness levels.
Further studies are needed to help determine the relationship between exercise and blood homocysteine. These studies need to clearly describe the participant's fitness level prior to the exercise program and detail the intensity, duration, and frequency of the exercises in the program. Furthermore, researchers need to care fully account for the many factors that influence homocysteine metabolism, such as dietary intake and blood vitamin levels of folate, vitamin B6, and vitamin B12, in order to reduce variability between individuals and studies. ↓ decreases blood homocysteine concentration ↑ increases blood homocysteine concentration ≠ no change in blood homocysteine concentration * impact of intensity and duration of exercise on blood homocysteine may be relative to individual fitness level ** impact of mode on blood homocysteine may depend on size of muscle mass involved and/or type of muscle contraction/loading
